Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

COCHLEAR LIMITED Regulatory Filings 2017

Aug 16, 2017

64685_rns_2017-08-16_b6e2748f-9917-49aa-ac0f-16f21fae594e.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

Appendix 4E (ASX Listing Rule 4.3A)

PRELIMINARY FINAL REPORT

Cochlear Limited ACN 002 618 073 30 June 2017

Results for announcement to the market

Results for announcement to the market
Movement A$000
Sales revenue up 7% to 1,239,733
Revenue up 11% to 1,253,838
Earnings before interest and tax (EBIT) up 20% to 315,600
Net profit attributable to members up 18% to 223,616
Basic earnings per share (cents) up 18% to 389.7
Net tangible assets per share at 30 June 2017 (cents) down 10% to 354.7
Net tangible assets per share at 30 June 2016 (cents) 392.0
Amount per Franked amount Conduit foreign
Dividends (distributions) security persecurity income persecurity
Final dividend payable $1.40 $1.40 $0.00
Interim dividend paid $1.30 $1.30 $0.00
Total $2.70 $2.70 $0.00
Previous corresponding financial year:
Final dividend paid $1.20 $1.20 $0.00
Interimdividend paid $1.10 $1.10 $0.00
Total $2.30 $2.30 $0.00
Record date for determining entitlements to the final dividend 20 September 2017
Dividend payment date 11 October 2017

Annual General Meeting

The Annual General Meeting will be held as follows:

The Annual General Meeting will be held as follows:
PlaceDateTime Australian Securities ExchangeExchange Square Auditorium20 Bridge Street,Sydney
17 October 2017
10:00am

Additional Appendix 4E disclosure requirements can be found in the 2017 Annual Report lodged with this document which contains the Financial Statements for the year ended 30 June 2017. This report is based on the Financial Statements for the year ended 30 June 2017 which have been audited by KPMG.